These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8544093)

  • 1. Microencapsulation of lobster carotenoids within poly(vinyl alcohol) and poly(D,L-lactic acid) membranes.
    Sun ZM; Poncelet D; Conway J; Neufeld RJ
    J Microencapsul; 1995; 12(5):495-504. PubMed ID: 8544093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microencapsulation using poly(DL-lactic acid). IV: Effect of storage on the microcapsule characteristics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):375-83. PubMed ID: 2384839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational molecular modeling and structural rationalization for the design of a drug-loaded PLLA/PVA biopolymeric membrane.
    Sibeko B; Pillay V; Choonara YE; Khan RA; Modi G; Iyuke SE; Naidoo D; Danckwerts MP
    Biomed Mater; 2009 Feb; 4(1):015014. PubMed ID: 19075365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrone loaded poly(l-lactic acid) microspheres: preparation, evaluation and in vitro release kinetics.
    Parikh BV; Upadrashta SM; Neau SH; Nuessle NO
    J Microencapsul; 1993; 10(2):141-53. PubMed ID: 8331489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encapsulation of Amikacin into Microparticles Based on Low-Molecular-Weight Poly(lactic acid) and Poly(lactic acid-
    Glinka M; Filatova K; Kucińska-Lipka J; Bergerova ED; Wasik A; Sedlařík V
    Mol Pharm; 2021 Aug; 18(8):2986-2996. PubMed ID: 34196555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):297-325. PubMed ID: 2200861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
    Liu Y; Pan J; Feng SS
    Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the size and uniformity of hollow poly(lactic acid) microcapsules fabricated from microbubble templates.
    Cornejo JJ; Daiguji H; Takemura F
    J Phys Chem B; 2011 Dec; 115(47):13828-34. PubMed ID: 22014126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of poly(vinyl alcohol) mediated prevention of aggregation and stabilization of insulin in nanoparticles.
    Rawat S; Gupta P; Kumar A; Garg P; Suri CR; Sahoo DK
    Mol Pharm; 2015 Apr; 12(4):1018-30. PubMed ID: 25644480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactic acid) microencapsulated oxytetracycline: in vitro and in vivo evaluation.
    Vidmar V; Smolcić-Bubalo A; Jalsenjak I
    J Microencapsul; 1984; 1(2):131-6. PubMed ID: 6336522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of newer quinolones from biodegradable systems based on poly(lactic acid).
    Andreopoulos AG
    J Biomater Appl; 1995 Oct; 10(2):163-70. PubMed ID: 8618209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of maltogenic α-amylase in poly(urethane-urea) shell: inverse emulsion method.
    Maciulyte S; Kochane T; Budriene S
    J Microencapsul; 2015; 32(6):547-58. PubMed ID: 26190216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of polyvinyl alcohol-co-oleylvinyl ether derivatives as tumor-specific cytotoxic systems.
    Orienti I; Zuccari G; Carosio R; Montaldo PG
    Biomacromolecules; 2005; 6(5):2875-80. PubMed ID: 16153130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of polylactic acid microcapsules containing ciprofloxacin.
    Yu WP; Wong JP; Chang TM
    J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microencapsulation using poly(DL-lactic acid). III: Effect of polymer molecular weight on the release kinetics.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(3):357-74. PubMed ID: 2384838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure.
    Allémann E; Leroux JC; Gurny R; Doelker E
    Pharm Res; 1993 Dec; 10(12):1732-7. PubMed ID: 7905625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.